Cite
TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2.
MLA
Vafaei, Nahid, et al. “TPP1 Variants in Iranian Patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2.” Molecular Syndromology, vol. 15, no. 1, Jan. 2024, pp. 30–36. EBSCOhost, https://doi.org/10.1159/000534100.
APA
Vafaei, N., Mohebbi, A., Rezaei, Z., Heidari, M., Hosseinpour, S., Zare Dehnavi, A., Ghamari, A., Salehipour, M., Rabbani, A., Mahdieh, N., & Ashrafi, M. R. (2024). TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2. Molecular Syndromology, 15(1), 30–36. https://doi.org/10.1159/000534100
Chicago
Vafaei, Nahid, Ali Mohebbi, Zahra Rezaei, Morteza Heidari, Sareh Hosseinpour, Ali Zare Dehnavi, Azin Ghamari, et al. 2024. “TPP1 Variants in Iranian Patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2.” Molecular Syndromology 15 (1): 30–36. doi:10.1159/000534100.